Check the latest share price of Sakar Healthcare Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Get live Sakar Healthcare Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 0.82 % |
3 Month Return | + 32.68 % |
1 Year Return | -5.32 % |
3 Year Return | + 92.56 % |
5 Year Return | + 526.6 % |
Market Stats | |
Previous Close | ₹312.60 |
Open | ₹309.75 |
Volume | 16.45K |
Upper Circuit | ₹375.10 |
Lower Circuit | ₹250.10 |
Check Sakar Healthcare Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹687.69 Cr
Return on Equity (ROE)
5.36
PE Ratio (TTM)
39.11
Return on capital employed (ROCE)
7.36
Industry PE ratio
57.39
Beta (LTM)
0.61
P/B Ratio
3.11
Dividend Yield
0PEG Ratio
16.1
Quarterly Earnings Growth YOY
84.62
EPS (TTM)
5.37
Sector
Pharmaceuticals
Book Value
118.41
Technical Analysis
Bullish
View Technical Analysis
Investing in Sakar Healthcare Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Sakar Healthcare Ltd or SAKAR on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Sakar Healthcare Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Sakar Healthcare Ltd with just a few clicks!
Track how Sakar Healthcare Ltd P/E has moved over time to understand its valuation trends.
Sakar Healthcare Ltd in the last 5 years
Lowest (13.06x)
May 12, 2022
Today (39.11x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (71.76x)
January 24, 2024
Today’s Price to Earnings Ratio: 39.11x
Get the annual and quarterly financial summary of Sakar Healthcare Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Sakar Healthcare Ltd.
Sakar Healthcare Ltd’s net profit jumped 84.62% since last year same period to ₹5.76Cr in the Q4 2024-2025. On a quarterly growth basis, Sakar Healthcare Ltd has generated 27.15% jump in its net profits since last 3-months.
Read More about Earnings ResultsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Sakar Healthcare Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 53.58% | 0.00 | |
Foreign Institutions | 13.61% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 21.85% | 0.00 | |
Others | 10.97% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Sakar Healthcare Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 687.69 | 105.32% | 0.62 | 11 | 153 | |
NA | 6.24 | 5.19% | 5.69 | NA | NA | |
NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
NA | 69.91 | 6.88% | 0.78 | 2 | 45 |
Latest news and events in one place to help you make informed investing decisions in Sakar Healthcare Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 4 quarters, 41.61 Cr → 50.42 Cr (in ₹), with an average increase of 6.1% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 13.58% to 13.61% in Mar 2025 quarter
Profit Spike
Netprofit is up for the last 2 quarters, 4.53 Cr → 5.76 Cr (in ₹), with an average increase of 21.4% per quarter
Price Rise
In the last 3 months, SAKAR stock has moved up by 32.7%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 38.5%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 50.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.58% of holdings in Mar 2025 quarter
Retail Holding Down
Retail Investor have decreased holdings from 21.96% to 21.85% in Mar 2025 quarter
Organisation | Sakar Healthcare Ltd |
Headquarters | Ahmedabad |
Industry | Pharmaceuticals |
CEO | Sanjay S Shah. |
E-voting on shares | Click here to vote |
Sakar Healthcare Ltd share price today stands at ₹313.3, Open: ₹309.75, Previous Close: ₹312.6, High: ₹314.85, Low: ₹306.35, 52 Week High: ₹374.5, 52 Week Low: ₹210.1.
Today's traded volume of Sakar Healthcare Ltd is 16.45K. Which means that 16.45K shares of Sakar Healthcare Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Sakar Healthcare Ltd is ₹687.69 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Sakar Healthcare Ltd’s 52 week high is ₹374.5 and 52 week low is ₹210.1. The current share price of Sakar Healthcare Ltd is ₹313.3, which is -16.34% down from its 52 week high and 49.12% up from its 52 week low.